{
    "clinical_study": {
        "@rank": "149582", 
        "acronym": "VIP", 
        "arm_group": [
            {
                "arm_group_label": "Soya Bean oil", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Vitamin D", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Increased Intestinal Permeability is detectable in clinically active Crohn's disease, in\n      stable Crohn's disease and is predictive of clinical relapse. Maintenance of the epithelial\n      barrier integrity is therefore essential for intestinal homeostasis. Vitamin D may have a\n      critical role in improving barrier function."
        }, 
        "brief_title": "Vitd and Barrier Function in IBD", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": "Crohn's Disease", 
        "condition_browse": {
            "mesh_term": "Crohn Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients must fulfill the clinical criteria for diagnosis  of CD as defined by\n             Lennard-Jones et al. (1976)\n\n          -  All patients must be in clinical remission for at least 1 month at study entry as\n             defined by a Crohn's Disease Activity Index (CDAI) of  <150\n\n          -  18-65 years\n\n          -  Patients on stable drug therapies for at least 1 month pre-enrolment\n\n          -  Sufficient English language ability to carry out the study requirements\n\n        Exclusion Criteria:\n\n          -  Symptomatic CD at study entry including CDAI >150\n\n          -  Pregnancy\n\n          -  Previous extensive small bowel resection (less than 200 cm of viable small bowel or a\n             loss of 50% or more of the small intestine)\n\n          -  Presence of an ileostomy or colostomy\n\n          -  Known hypersensitivity to vitamin D\n\n          -  Hypercalcaemia (corrected serum calcium > 2.66 mmol/L)\n\n          -  Those currently using supplemental vitamin D >800  IU/D\n\n          -  Diagnosis of any of the following: active tuberculosis, sarcoidosis,\n             hyperparathyroidism, renal failure, pseudohyperparathyroidism, malignancy, active,\n             lymphoma, short bowel syndrome\n\n          -  Antibiotic use in the 4 weeks prior to enrolment\n\n          -  Current use of bisphosphonates\n\n          -  Renal Impairment, Diabetes Mellitus\n\n          -  Patients participating in a concurrent RCT\n\n          -  Alcohol dependency"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01792388", 
            "org_study_id": "vip"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin D", 
                "description": "Capsule Form", 
                "intervention_name": "Vitamin D", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Soya Bean oil", 
                "description": "Capsule form", 
                "intervention_name": "Soya Bean oil", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Crohn's Disease", 
            "Vitamin D", 
            "Intestinal Permeability", 
            "Tara Raftery"
        ], 
        "lastchanged_date": "February 13, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "Adelaide and Meath Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dublin 24", 
                        "country": "Ireland"
                    }, 
                    "name": "Tallaght Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Ireland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vitamin D and Its Effects on Inflammation and Intestinal Permeability in Crohn's Disease in Remission", 
        "overall_official": {
            "affiliation": "Trinity College Dublin", 
            "last_name": "Maria O'Sullivan, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Ireland: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Lactulose, Mannitol, Sucralose Test", 
            "measure": "Change from Baseline Intestinal Permability from baseline and 3 months", 
            "safety_issue": "No", 
            "time_frame": "0 and 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01792388"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Dublin, Trinity College", 
            "investigator_full_name": "Tara Raftery", 
            "investigator_title": "Dr. Maria O'Sullivan, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Inflammatory markers from baseline to 3 months", 
                "safety_issue": "No", 
                "time_frame": "Baseline and  3months"
            }, 
            {
                "measure": "To assess change in antimicrobial peptide levels from baseline to 3 months", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 3 months"
            }
        ], 
        "source": "University of Dublin, Trinity College", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Calgary", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Queen Mary University of London", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Dublin, Trinity College", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}